Prognostic value of metastin expression in human pancreatic cancer.
about
Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinomaMetastasis suppressor genes at the interface between the environment and tumor cell growthKISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.Treatment effects of rhBMP-2 on invasiveness of oral carcinoma cell lines.Clinical and biological significance of KISS1 expression in prostate cancer.Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review).KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.The KISS1 metastasis suppressor: a good night kiss for disseminated cancer cellsKisspeptin/KISS1R System in Breast CancerTCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling.Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer.KiSS1 and its G-protein-coupled receptor GPR54 in cancer development and metastasis.KiSS-1 expression in oral squamous cell carcinoma and its prognostic significance.Biomarkers as predictors of recurrence following curative resection for pancreatic ductal adenocarcinoma: a review.Metastin is not involved in metastatic potential of non-small cell lung cancer.Kisspeptin-54 levels are increased in patients with colorectal cancer.Prognostic value of kisspeptin expression in nasopharyngeal carcinoma.KISS1/KISS1R in Cancer: Friend or Foe?
P2860
Q26739910-3B61EC01-9709-4D4A-AF2F-372079D94E17Q28394526-6E7F31F9-C1D9-4203-87AF-D2C66D972BBAQ34286070-26B280BC-B620-4CD5-93AB-B36943CA978CQ35491924-32A71BF3-C66C-47F7-B247-4D9EE831754BQ35952025-8B86B639-8760-4B16-870A-A0AD4D5C9504Q36216532-8CBE8528-A0E4-4C7B-BD67-A6F6F34BAC32Q36390202-B1A50EF2-C40F-4A85-986B-FCA12D57BA66Q36868969-57EA1A57-C0E7-4F52-9AA2-D86903127632Q37249506-4637F0FF-3B01-43C6-810C-A2DFC3E75F83Q37712367-18C98813-F198-4E6B-A59A-42F4BFCF03ABQ37885319-DDBE7634-77BD-45D9-A031-43D85320ED7DQ38018254-5334BC75-D429-4CD5-A104-5CEA3AF7BF3BQ38799495-DE903466-161D-4C06-9D78-3DABFEB54FF3Q42181162-7D2E5C0A-9CEB-484C-AC42-FDAF481C5B62Q51405170-C57EF4E1-A3B8-4B01-8C4C-95844A191A48Q53923489-D1E987DA-A9E9-41C0-B426-A83992A269C3Q54568742-492744AD-6DED-430E-B19D-4F8005FDA96AQ57170895-D3265411-7AE7-4503-9A9F-EEE6C6EC6050
P2860
Prognostic value of metastin expression in human pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic value of metastin expression in human pancreatic cancer.
@en
Prognostic value of metastin expression in human pancreatic cancer.
@nl
type
label
Prognostic value of metastin expression in human pancreatic cancer.
@en
Prognostic value of metastin expression in human pancreatic cancer.
@nl
prefLabel
Prognostic value of metastin expression in human pancreatic cancer.
@en
Prognostic value of metastin expression in human pancreatic cancer.
@nl
P2093
P2860
P356
P1476
Prognostic value of metastin expression in human pancreatic cancer
@en
P2093
Atsushi Kida
Fumihiko Katagiri
Kazuyuki Nagai
Kenji Tomita
Masayuki Koizumi
Nobutaka Fujii
Shinji Uemoto
Shinya Oishi
Tatsuo Ito
Toshihiko Masui
P2860
P2888
P356
10.1186/1756-9966-28-9
P577
2009-01-21T00:00:00Z
P5875
P6179
1024457499